NDA 206026, held by Air Liquide Healthcare America Corp. Helium.
As of Nov 14, 2026, NDA 206026 (Helium, Usp), held by Air Liquide Healthcare America Corp, was first approved by FDA on Sep 7, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 7, 2013 | Original applicationMEDGAS · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Helium, UspN/A · gas;inhalation | Helium | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
